BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15951400)

  • 1. The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts.
    Pálfi A; Tóth A; Kulcsár G; Hantó K; Deres P; Bartha E; Halmosi R; Szabados E; Czopf L; Kálai T; Hideg K; Sümegi B; Tóth K
    J Pharmacol Exp Ther; 2005 Oct; 315(1):273-82. PubMed ID: 15951400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
    Bartha E; Kiss GN; Kalman E; Kulcsár G; Kálai T; Hideg K; Habon T; Sumegi B; Toth K; Halmosi R
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):253-61. PubMed ID: 18806606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved poststorage cardiac function by poly (ADP-ribose) polymerase inhibition: role of phosphatidylinositol 3-kinase Akt pathway.
    Gao L; Kwan JC; Macdonald PS; Yang L; Preiss T; Hicks M
    Transplantation; 2007 Aug; 84(3):380-6. PubMed ID: 17700164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
    Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
    Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
    Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
    J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of kinase cascade activation and heat shock protein expression by poly(ADP-ribose) polymerase inhibition in doxorubicin-induced heart failure.
    Bartha E; Solti I; Szabo A; Olah G; Magyar K; Szabados E; Kalai T; Hideg K; Toth K; Gero D; Szabo C; Sumegi B; Halmosi R
    J Cardiovasc Pharmacol; 2011 Oct; 58(4):380-91. PubMed ID: 21697725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
    Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model.
    Yamazaki K; Miwa S; Ueda K; Tanaka S; Toyokuni S; Unimonh O; Nishimura K; Komeda M
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):270-5. PubMed ID: 15296882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice.
    Veres B; Radnai B; Gallyas F; Varbiro G; Berente Z; Osz E; Sumegi B
    J Pharmacol Exp Ther; 2004 Jul; 310(1):247-55. PubMed ID: 14999056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
    Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass.
    Khan TA; Ruel M; Bianchi C; Voisine P; Komjáti K; Szabo C; Sellke FW
    J Am Coll Surg; 2003 Aug; 197(2):270-7. PubMed ID: 12892811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction.
    Murthy KG; Xiao CY; Mabley JG; Chen M; Szabó C
    Shock; 2004 Mar; 21(3):230-4. PubMed ID: 14770035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of caspase-9 and poly(ADP-ribose) polymerase inhibitors on ischemia-reperfusion-induced myocardial injury.
    Sodhi RK; Singh M; Singh N; Jaggi AS
    Arch Pharm Res; 2009 Jul; 32(7):1037-43. PubMed ID: 19641885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways.
    Rafiee P; Shi Y; Su J; Pritchard KA; Tweddell JS; Baker JE
    Basic Res Cardiol; 2005 May; 100(3):187-97. PubMed ID: 15611843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial protective effect of FR167653; a novel cytokine inhibitor in ischemic-reperfused rat heart.
    Aleshin A; Sawa Y; Ono M; Funatsu T; Miyagawa S; Matsuda H
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):974-80. PubMed ID: 15519192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.
    Zhang LQ; Qi GX; Jiang DM; Tian W; Zou JL
    Shock; 2012 May; 37(5):492-500. PubMed ID: 22266967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
    Zhu M; Feng J; Lucchinetti E; Fischer G; Xu L; Pedrazzini T; Schaub MC; Zaugg M
    Cardiovasc Res; 2006 Oct; 72(1):152-62. PubMed ID: 16901477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties.
    Kutala VK; Khan M; Mandal R; Ganesan LP; Tridandapani S; Kalai T; Hideg K; Kuppusamy P
    J Pharmacol Exp Ther; 2006 Jun; 317(3):921-8. PubMed ID: 16467453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preconditioning effects of steroids and hyperoxia on cardiac ischemia-reperfusion injury and vascular reactivity.
    Kaljusto ML; Stensløkken KO; Mori T; Panchenko A; Frantzen ML; Valen G; Vaage J
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):355-63. PubMed ID: 18221880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart.
    Knight RJ; Buxton DB
    Biochem Biophys Res Commun; 1996 Jan; 218(1):83-8. PubMed ID: 8573181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.